GlassScriptPhysician profile
Ashley Carter
NPI 1073062154
$7,100.47
in general payments reported to CMS, 2019-2025
8 companies · $152 in 2025
The $152 reported for 2025 was less than what a typical Primary Care provider received nationally (typical 2025 total: $170).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $23.93 · 2022: $2,102 · 2023: $4,427 · 2024: $396 · 2025: $152.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,449 · Travel and Lodging: $2,395 · Education: $131.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,449.26 |
| Travel and Lodging | $2,394.51 |
| Education | $131.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $2,806.55 | 2023-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Medtronic, INC. | $2,579.40 | 2022-2025 | Corevalve Evolut R |
| Boston Scientific Corporation | $1,113.85 | 2022-2025 | Watchman Access System, Farapulse |
| Novartis Pharmaceuticals Corporation | $187.79 | 2021-2024 | |
| Abbott Laboratories | $167.75 | 2022-2024 | Navitor |
| Cardiva Medical, INC. | $120.18 | 2024-2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Novo Nordisk INC | $99.49 | 2023 | |
| Pfizer INC. | $25.46 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Carter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.